Episode

Episode 62. Unpacking MIDAS Trial in Myeloma with Dr. Meera Mohan

Podcast
Blood Cancer Talks
Published
Jul 9, 2025
Duration seconds
1505
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/93af17a0
Audio
https://media.transistor.fm/93af17a0/44775c24.mp3
JSON
/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-62-unpacking-midas-trial-in-myeloma-with-dr-meera-mohan
Markdown
/podcast/blood-cancer-talks-5570002/episode-62-unpacking-midas-trial-in-myeloma-with-dr-meera-mohan.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-62-unpacking-midas-trial-in-myeloma-with-dr-meera-mohan/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-62-unpacking-midas-trial-in-myeloma-with-dr-meera-mohan.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, we dissect the phase 3 MIDAS trial in newly diagnosed transplant-eligible multiple myeloma with Dr. Meera Mohan. https://pubmed.ncbi.nlm.nih.gov/39841461/ https://pubmed.ncbi.nlm.nih.gov/40459097/